U.S. Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Whole Genome Sequencing, Whole Exon Sequencing, Targeted Sequencing & Resequencing), By Workflow, By End Use, Regions, And Segment Forecasts 2018 To 2024

Market Segmentation

• U.S. Clinical Oncology NGS Outlook, by Technology (Revenue, USD Million, 2013 - 2024)
  • Targeted Sequencing & Resequencing
  • Whole Exon Sequencing
  • Whole Genome Sequencing
• U.S. Clinical Oncology NGS Outlook, by Workflow (Revenue, USD Million, 2013 - 2024)
  • NGS Sequencing
  • NGS Pre-Sequencing
  • NGS Data Analysis
    • NGS Tertiary Data Analysis
    • NGS Secondary Data Analysis
    • NGS Primary Data Analysis
• U.S. Clinical Oncology NGS Outlook, by End Use (Revenue, USD Million, 2013 - 2024)
  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other Users

Report Content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Application Segments Prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2013 to 2024
• U.S. Revenue estimates for technology up to 2024
• U.S. Revenue estimates for workflow up to 2024
• U.S. Revenue estimates for end use up to 2024

Company financial performance